The present invention relates to a composition for the prevention, improvement and treatment of blood cancer comprising a compound derived from Yangjeon extract as an active ingredient. , and delays the cell cycle progression and increases the number of apoptotic cells, thereby exhibiting apoptosis-inducing activity in leukemia cells, so it can be used for the purpose of preventing or treating hematologic cancer.
展开▼
